COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

The following is a summary of “Skin cancer risk in over 200.000 patients with haematologic malignancies in 30 years; a ...

Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention ...

Of the remaining 10 cases (14%), 3 were F. mortiferum, 2 were F. peridonticum, and 5 could only reliably be identified as Fusobacterium spp. The overall annual incidence of Fusobacterium ...

For patients with compensated metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis and obesity, me ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.